JPH0260318B2 - - Google Patents
Info
- Publication number
- JPH0260318B2 JPH0260318B2 JP2080883A JP2080883A JPH0260318B2 JP H0260318 B2 JPH0260318 B2 JP H0260318B2 JP 2080883 A JP2080883 A JP 2080883A JP 2080883 A JP2080883 A JP 2080883A JP H0260318 B2 JPH0260318 B2 JP H0260318B2
- Authority
- JP
- Japan
- Prior art keywords
- homocysteine
- sah
- cells
- ifo
- adenosine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 claims description 34
- 239000002126 C01EB10 - Adenosine Substances 0.000 claims description 17
- 229960005305 adenosine Drugs 0.000 claims description 17
- FFFHZYDWPBMWHY-VKHMYHEASA-N L-homocysteine Chemical compound OC(=O)[C@@H](N)CCS FFFHZYDWPBMWHY-VKHMYHEASA-N 0.000 claims description 15
- 244000005700 microbiome Species 0.000 claims description 12
- ZJUKTBDSGOFHSH-WFMPWKQPSA-N S-Adenosylhomocysteine Chemical compound O[C@@H]1[C@H](O)[C@@H](CSCC[C@H](N)C(O)=O)O[C@H]1N1C2=NC=NC(N)=C2N=C1 ZJUKTBDSGOFHSH-WFMPWKQPSA-N 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 5
- 230000002194 synthesizing effect Effects 0.000 claims description 5
- 239000012736 aqueous medium Substances 0.000 claims description 4
- 230000001580 bacterial effect Effects 0.000 description 23
- 238000006243 chemical reaction Methods 0.000 description 17
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 16
- 239000000243 solution Substances 0.000 description 15
- 238000000034 method Methods 0.000 description 13
- 239000000758 substrate Substances 0.000 description 9
- 238000005119 centrifugation Methods 0.000 description 8
- 239000007788 liquid Substances 0.000 description 8
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 7
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 7
- 239000002609 medium Substances 0.000 description 7
- 108090000790 Enzymes Proteins 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 6
- 239000008057 potassium phosphate buffer Substances 0.000 description 6
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 5
- 239000007864 aqueous solution Substances 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 239000012064 sodium phosphate buffer Substances 0.000 description 5
- 239000006228 supernatant Substances 0.000 description 5
- FFFHZYDWPBMWHY-UHFFFAOYSA-N HOMOCYSTEINE Chemical compound OC(=O)C(N)CCS FFFHZYDWPBMWHY-UHFFFAOYSA-N 0.000 description 4
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- MEFKEPWMEQBLKI-AIRLBKTGSA-N S-adenosyl-L-methioninate Chemical compound O[C@@H]1[C@H](O)[C@@H](C[S+](CC[C@H](N)C([O-])=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 MEFKEPWMEQBLKI-AIRLBKTGSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 238000012136 culture method Methods 0.000 description 3
- 238000012258 culturing Methods 0.000 description 3
- 230000000813 microbial effect Effects 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- YODZTKMDCQEPHD-UHFFFAOYSA-N thiodiglycol Chemical compound OCCSCCO YODZTKMDCQEPHD-UHFFFAOYSA-N 0.000 description 3
- 229950006389 thiodiglycol Drugs 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000222122 Candida albicans Species 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 239000001888 Peptone Substances 0.000 description 2
- 108010080698 Peptones Proteins 0.000 description 2
- 241000235070 Saccharomyces Species 0.000 description 2
- 244000288561 Torulaspora delbrueckii Species 0.000 description 2
- 235000014681 Torulaspora delbrueckii Nutrition 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- ROOXNKNUYICQNP-UHFFFAOYSA-N ammonium persulfate Chemical compound [NH4+].[NH4+].[O-]S(=O)(=O)OOS([O-])(=O)=O ROOXNKNUYICQNP-UHFFFAOYSA-N 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 229940095731 candida albicans Drugs 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 239000003729 cation exchange resin Substances 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000017858 demethylation Effects 0.000 description 2
- 238000010520 demethylation reaction Methods 0.000 description 2
- AXZAYXJCENRGIM-UHFFFAOYSA-J dipotassium;tetrabromoplatinum(2-) Chemical compound [K+].[K+].[Br-].[Br-].[Br-].[Br-].[Pt+2] AXZAYXJCENRGIM-UHFFFAOYSA-J 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 description 2
- 235000019319 peptone Nutrition 0.000 description 2
- IYDGMDWEHDFVQI-UHFFFAOYSA-N phosphoric acid;trioxotungsten Chemical compound O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.OP(O)(O)=O IYDGMDWEHDFVQI-UHFFFAOYSA-N 0.000 description 2
- 229910001487 potassium perchlorate Inorganic materials 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- DLYUQMMRRRQYAE-UHFFFAOYSA-N tetraphosphorus decaoxide Chemical compound O1P(O2)(=O)OP3(=O)OP1(=O)OP2(=O)O3 DLYUQMMRRRQYAE-UHFFFAOYSA-N 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 241000222128 Candida maltosa Species 0.000 description 1
- 241001530515 Candida sake Species 0.000 description 1
- 241000222178 Candida tropicalis Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 241000235646 Cyberlindnera jadinii Species 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- ZTVZLYBCZNMWCF-WDSKDSINSA-N L,L-homocystine zwitterion Chemical compound OC(=O)[C@@H](N)CCSSCC[C@H](N)C(O)=O ZTVZLYBCZNMWCF-WDSKDSINSA-N 0.000 description 1
- 241000235048 Meyerozyma guilliermondii Species 0.000 description 1
- KWYHDKDOAIKMQN-UHFFFAOYSA-N N,N,N',N'-tetramethylethylenediamine Chemical compound CN(C)CCN(C)C KWYHDKDOAIKMQN-UHFFFAOYSA-N 0.000 description 1
- 241000235072 Saccharomyces bayanus Species 0.000 description 1
- 241000877399 Saccharomyces chevalieri Species 0.000 description 1
- 241000582914 Saccharomyces uvarum Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 241000235033 Zygosaccharomyces rouxii Species 0.000 description 1
- 241000191335 [Candida] intermedia Species 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 229960001570 ademetionine Drugs 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- 229910001870 ammonium persulfate Inorganic materials 0.000 description 1
- 108010038083 amyloid fibril protein AS-SAM Proteins 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- UZUODNWWWUQRIR-UHFFFAOYSA-L disodium;3-aminonaphthalene-1,5-disulfonate Chemical compound [Na+].[Na+].C1=CC=C(S([O-])(=O)=O)C2=CC(N)=CC(S([O-])(=O)=O)=C21 UZUODNWWWUQRIR-UHFFFAOYSA-L 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- KIWQWJKWBHZMDT-UHFFFAOYSA-N homocysteine thiolactone Chemical compound NC1CCSC1=O KIWQWJKWBHZMDT-UHFFFAOYSA-N 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 238000009629 microbiological culture Methods 0.000 description 1
- 239000011785 micronutrient Substances 0.000 description 1
- 235000013369 micronutrients Nutrition 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- ZIUHHBKFKCYYJD-UHFFFAOYSA-N n,n'-methylenebisacrylamide Chemical compound C=CC(=O)NCNC(=O)C=C ZIUHHBKFKCYYJD-UHFFFAOYSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 238000004816 paper chromatography Methods 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 229920001467 poly(styrenesulfonates) Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Description
本発明は特定微生物の菌体を酵素源として用い
るアデノシンとホモシステインからS−アデノシ
ル−L−ホモシステインを効率良く酵素合成して
採取する方法に関する。
S−アデノシル−L−ホモシステイン(以下、
SAHと略称する)は、生体内においてS−アデ
ノシルメチオニン(以下、SAMと略称する)が
関与するメチル基供与反応で生じる重要な生理活
性物質である。而して、近時かかるSAHに鎮静
剤、睡眠誘発剤などとしての効果が見い出されて
おり、その大量生産が期待されている。
従来、SAHの製造方法としてはサツカロマイ
セス属またはキヤンデイダ属の酵母から抽出する
方法〔例えばアーカイブズ・オブ・バイオケミス
トリー・アンド・バイオフイジツクス(Arch.
Biochem.Biophys)69、575(1962)〕、SAMから
の酵素的脱メチル法〔例えばジヤーナル・オブ・
バイオロジカル・ケミストリー(J.Biol.Chem)
240、2512(1965)〕、SAMからの化学的脱メチル
法(例えば特公昭45−37536号)などが知られて
いる。しかしながら、これらほ方法はいずれも非
常に経費がかかり、工業的製造法とは言い難い。
一方、アデノシンとホモシステインをサツカロ
マイセス属またはキヤンデイダ属酵母の菌体抽出
物の存在下に酵素合成する方法〔例えばアーカイ
ブズ・オブ・バイオケミストリー・アンド・バイ
オフイジツクス(Arch・Biochem・Biophys)
69、575(1962)〕も知られている。しかし、この
方法は菌体からの抽出物を用いる点で操作性に難
があり、必ずしも実用的とは言い難い。
本発明者らは以上のように実状に鑑み、SAH
の酵素的合成法に関して種々検討を加えた結果、
サツカロマイセス属またはキヤンデイダ属に属す
る菌体を酵素源として用いた時に、アデノシンと
ホモシステインから簡単に、しかも効率良く
SAHが構成できることを見い出し本発明を完成
した。
かくして本発明によれば、サツカロマイセス属
またはキヤンデイダ属に属しアデノシンとホモシ
ステインよりSAHを合成する能力を有する微生
物の菌体の存在下にアデノシンとホモシステイン
を水性媒体中で接触させて反応せしめ、SAHを
合成して採取することを特徴とするSAHの製造
法が提供される。
本発明において酵素源として用いられる微生物
は上記の属に属し、生菌体または乾燥菌体の形態
でアデノシンとホモシステインからSAHを合成
できる能力を有するものであればいずれでも良
く、その具体例としてはサツカロマイセス・セレ
ビジエ(Saccharomyces cerevisiae)IFO
1805、サツカロマイセス・セレビジエIAM
4175、サツカロマイセス・シエバリエリ
(Saccharomyces chevalieri)IFO 1727、サツ
カロマイセス・エキシグース(Saccharomyces
exiguus)IFO 0215、サツカロマイセス・ウバル
ム(Saccharomyces uvarum)IFO 0565、サツ
カロマイセス・フアーメンタチ
(Saccharomyces fermentati)IFO 0422、サツ
カロマイセス・ロウキシー(Saccharomyces
rouxii)IFO 0487、サツカロマイセス・バヤヌ
ス(Saccharomyces bayanus)IFO 0206、サツ
カロマイセス・ロゼイ(Saccharomyces rosei)
IFO 1172、サツカロマイセス・デルプリユツキ
ー(Saccharomyces delburueckii)IFO 0955、
キヤンデイダ・ウチリス(Candida utilis)IFO
0396、キヤンデイダ・ギリエルモンデイー
(Candida guilliermondii)IFO 0566、キヤンデ
イダ・サケ(Candida sake)IFO 1633、キヤン
デイダ・トロピカリス(Candida tropicalis)
IFO 0587、キヤンデイダ・クルセイ(Candida
krusei)IFO 0013、キヤンデイダ・マセイドニ
エンシス(Candida macedoniensis)IFO 0706、
キヤンデイダ・シユードトロピカリス(Candida
pseudotropicalis)IFO 1065、キヤンデイダ・マ
ルトーサ(Candida maltosa)ATCC 38042、キ
ヤンデイダ・インターメデイア(Candida
intermedia)IFO 0761、キヤンデイダ・アルビ
カンス(Candida albicans)IFO 1594などが挙
げられる。また市販パン酵母、清酒酵母なども前
記の属に属するかぎり使用することができる。さ
らにこれらの菌の天然及び人工変異菌であつても
SAH合成能を有するかぎり同様に使用すること
ができる。
本発明におけるSAHの合成方法は微生物の生
菌体又は乾燥菌体の形態で菌体内酵素の作用を利
用するものであるが、この酵素は微生物を通常の
方法で培養する事により調整する事ができる。
微生物を培養する培地は、炭素源、窒素源、無
機塩、有機微量栄養源を含有する通常の培地でよ
く、微生物の種類に応じて適宜選択して使用すれ
ばよい。また培養方法は通常液体培地で行なわれ
るが、固体表面培養によつても行うことができ
る。培養条件は微生物の種類に応じて適宜選択す
れば良く、温度10〜60℃、PH3〜10の範囲が用い
られるが、一般的には温度20〜40℃、PH4〜9の
範囲で10〜120時間培養すれば良い。培養中には
通気・撹拌を行つて微生物の生育を促進されるこ
ともできる。
本発明におけるSAHの合成反応には、前記の
ようにして培養した微生物が生菌体または乾燥菌
体の形態で使用される。例えば、微生物の培養液
中の菌体をそのまま使用してもSAHの合成反応
は進行するが、培養液中の成分が障害になる場合
や菌体量を多く使用したい場合には培養液から分
離した菌体を用いることが好ましい。菌体は生菌
体のままで充分に使用目的を達するが、貯蔵ある
いは取扱いの便宜から風乾菌体、凍結乾燥菌体、
アセトン菌体などのような乾燥菌体として用いる
こともできる。また、菌体を常法に従つて固定化
して使用することもできる。
本発明におけるSAH合成反応は酵素反応基質
であるアデノシンとホモシステインとを微生物菌
体の存在下に水性媒体中で接触させることによつ
て行なわれる。反応に供されるホモシステインは
L体、DL体のいずれであつても使用することが
できる。また反応の条件は適宜選択すればよく、
基質濃度としてアデノシンを1mM以上、好まし
くは2〜20mM、ホモシステイン濃度を1mM以
上、好ましくは2〜200mMとすればよい。
なお、本発明におけるホモシステインなる用語
は反応系内においてホモシステインを供給する物
質(例えばホモシスチン、ホモシステインチオラ
クトンなど)をも含むものとして理解されるべき
である。
反応における系のPHは4〜12、好ましくは6〜
10に保てばよく、PHの調整は通常の方法、たとえ
ばリン酸カリウムバツフアー、リン酸ナトリウム
バツフアー、トリスバツフアー、塩化アンモニウ
ムバツフアー、グリシンバツフアーなどによつて
調整すればよい。
反応温度は、反応がよく進行し酵素活性、基質
および生成物に影響のない温度であればよく、通
常は15〜60℃、好ましくは20〜50℃である。反応
時間は基質のSAHへの転化率が増大するように
設定すればよく、バツチ式の場合、通常0.1〜48
時間好ましくは0.5〜36時間である。その他目的
に応じて水性媒体中にアセトン、エタノールの如
き有機溶媒や各種の界面活性剤を添加して反応を
行わせることもできる。
かくしてSAHを含有する反応液が得られるが、
該反応液からSAHを採取する方法は公知方法に
よればよい。その分離法としては、例えばSAH
含有液を強酸性カチオン交換樹脂に接触させて
SAHを吸着させた後、硫酸で溶出させ、溶出液
にリンタングステン酸を加えてSAHを沈殿させ
る方法、SAH含有液を活性炭に接触させてSAH
を吸着させた後、エタノール/水/濃アンモニア
水(5:50:1)で溶出させ、溶出液を減圧下濃
縮して濃縮物のPHを酢酸で7に調節した後、
SAHを0℃で晶出させる方法などが例示される。
以下に実施例を挙げて本発明をさらに具体的に
説明する。ただし本発明はこれらの例のみに限定
されるものではない。
なお、実施例におけるSAHの定量は次のよう
にして行つた。すなわち、反応終了後、反応液を
直ちに0〜5℃に冷却し過塩素酸を添加して反応
を停止した。次いで遠心分離にて不溶物を除去し
たのち、得られた上澄液にリン酸カリウムバツフ
アー(PH7.0)を添加して、生成した過塩素酸カ
リウムを遠心分離により除去した。かくして得ら
れた上澄液の所定量を採取して高速液体クロマト
グラフイー(日立製作所製、638−30型、カラ
ム:Cosmocil 5C18、Detecter:UV260nm)を
用いることによりSAHの定量を実施した。
実施例 1
グルコース5g/dl、ペプトン0.5g/dl、酵
母エキス0.1g/dl、KH2PO40.2g/dl、
K2HPO40.1g/dl、MgSO4・7H2O0.02g/dl、
寒天2g/dlからなる寒天斜面培地(PH6.0)で
28℃、48時間培養した第1表記載の菌株1白金耳
を、グルコース5g/dl、ペプトン0.5g/dl、
酵母エキス0.1g/dl、KH2PO40.2g/dl、
K2HPO40.1g/dl、Mg SO4・7H2O0.02g/dl
からなりPH6.5に調整、加熱滅菌した液体培地10
mlに植菌し、28℃で40時間振盪培養を行なつた。
遠心分離にて集菌し、0.1Mリン酸ナトリウム
バツフアー(PH8.5)で洗浄した後、菌体をアデ
ノシン2mM、DLホモシステイン4mM、リン
酸ナトリウムバツフアー(PH8.5)100mMからな
る基質溶液1mlに懸濁し、30℃で4時間振盪して
反応させた。SAHの収量を測定し、その結果を
第1表に示した。
The present invention relates to a method for efficiently enzymatically synthesizing and collecting S-adenosyl-L-homocysteine from adenosine and homocysteine using cells of specific microorganisms as an enzyme source. S-adenosyl-L-homocysteine (hereinafter referred to as
SAH (abbreviated as SAH) is an important physiologically active substance generated in vivo through a methyl group-donating reaction involving S-adenosylmethionine (hereinafter abbreviated as SAM). Recently, SAH has been found to be effective as a sedative, sleep-inducing agent, etc., and its mass production is expected. Conventionally, the method for producing SAH is to extract it from yeast of the genus Satucharomyces or Candeida [for example, the method described in Archives of Biochemistry and Biophysics (Arch.
Biochem. Biophys) 69, 575 (1962)], enzymatic demethylation methods from SAM [e.g.
Biological Chemistry (J.Biol.Chem)
240, 2512 (1965)], and a chemical demethylation method from SAM (for example, Japanese Patent Publication No. 37536/1983). However, all of these methods are very expensive and cannot be called industrial production methods. On the other hand, a method of enzymatically synthesizing adenosine and homocysteine in the presence of a bacterial cell extract of yeast of the genus Satucharomyces or Candeida [for example, Archives of Biochemistry and Biophysics (Arch, Biochem, Biophys)]
69, 575 (1962)] is also known. However, this method is difficult to operate because it uses extracts from bacterial cells, and is not necessarily practical. In view of the actual situation as described above, the inventors of the present invention
As a result of various studies on the enzymatic synthesis method of
When bacterial cells belonging to the genus Satucharomyces or Candeida are used as an enzyme source, adenosine and homocysteine can be easily and efficiently extracted from adenosine and homocysteine.
We discovered that SAH can be constructed and completed the present invention. Thus, according to the present invention, adenosine and homocysteine are brought into contact with each other in an aqueous medium in the presence of the cells of a microorganism belonging to the genus Satucharomyces or Candeida that has the ability to synthesize SAH from adenosine and homocysteine, and thereby react with SAH. Provided is a method for producing SAH, which comprises synthesizing and collecting SAH. The microorganism used as an enzyme source in the present invention may belong to the above-mentioned genus and may be any microorganism that has the ability to synthesize SAH from adenosine and homocysteine in the form of live or dry cells. is Saccharomyces cerevisiae (Saccharomyces cerevisiae) IFO
1805, Satucharomyces cerevisiae IAM
4175, Saccharomyces chevalieri IFO 1727, Saccharomyces exigus
exiguus) IFO 0215, Saccharomyces uvarum IFO 0565, Saccharomyces fermentati IFO 0422, Saccharomyces rouxii
rouxii) IFO 0487, Saccharomyces bayanus IFO 0206, Saccharomyces rosei
IFO 1172, Saccharomyces delburueckii IFO 0955,
Candida utilis IFO
0396, Candida guilliermondii IFO 0566, Candida sake IFO 1633, Candida tropicalis
IFO 0587, Candida Crucei
krusei) IFO 0013, Candida macedoniensis (Candida macedoniensis) IFO 0706,
Candida seudotropicalis
pseudotropicalis) IFO 1065, Candida maltosa ATCC 38042, Candida intermediaa (Candida
intermedia) IFO 0761, Candida albicans (Candida albicans) IFO 1594, etc. Commercially available baker's yeast, sake yeast, etc. can also be used as long as they belong to the above-mentioned genus. Furthermore, even natural and artificial mutants of these bacteria
As long as it has the ability to synthesize SAH, it can be used in the same way. The method for synthesizing SAH in the present invention utilizes the action of intracellular enzymes in the form of living or dried microbial cells, but this enzyme can be prepared by culturing microorganisms in a conventional manner. can. The medium for culturing the microorganism may be a conventional medium containing a carbon source, a nitrogen source, an inorganic salt, and an organic micronutrient source, and may be appropriately selected and used depending on the type of microorganism. The culture method is usually carried out in a liquid medium, but it can also be carried out by solid surface culture. Culture conditions may be selected appropriately depending on the type of microorganism, and a temperature of 10 to 60℃ and a pH of 3 to 10 are used, but generally, a temperature of 20 to 40℃ and a pH of 4 to 9 and a pH of 10 to 120 are used. All you have to do is cultivate it for a while. The growth of microorganisms can be promoted by aeration and stirring during culturing. In the SAH synthesis reaction of the present invention, the microorganisms cultured as described above are used in the form of live cells or dry cells. For example, the SAH synthesis reaction will proceed even if the cells in the microbial culture solution are used as they are, but if the components in the culture solution become an obstacle or if you want to use a large amount of bacteria, they can be separated from the culture solution. It is preferable to use microbial cells that have been prepared. Bacterial cells can be used as viable cells, but for convenience in storage and handling, air-dried cells, freeze-dried cells,
It can also be used as dried bacterial cells such as acetone bacterial cells. Furthermore, the bacterial cells can be immobilized and used according to a conventional method. The SAH synthesis reaction in the present invention is carried out by bringing adenosine, which is an enzyme reaction substrate, into contact with homocysteine in an aqueous medium in the presence of microbial cells. Homocysteine to be subjected to the reaction can be used in either the L form or the DL form. In addition, the reaction conditions may be selected appropriately.
The substrate concentration may be adenosine of 1 mM or more, preferably 2 to 20 mM, and homocysteine concentration of 1 mM or more, preferably 2 to 200 mM. Note that the term homocysteine in the present invention should be understood to include substances that supply homocysteine in the reaction system (eg, homocysteine, homocysteine thiolactone, etc.). The pH of the system in the reaction is 4-12, preferably 6-12.
It is sufficient to maintain the pH at 10, and the pH may be adjusted by a conventional method, for example, using a potassium phosphate buffer, a sodium phosphate buffer, a Tris buffer, an ammonium chloride buffer, a glycine buffer, etc. The reaction temperature may be any temperature that allows the reaction to proceed well and does not affect enzyme activity, substrates and products, and is usually 15 to 60°C, preferably 20 to 50°C. The reaction time can be set to increase the conversion rate of the substrate to SAH, and in the case of a batch method, it is usually 0.1 to 48
The time is preferably 0.5 to 36 hours. Depending on the purpose, the reaction can also be carried out by adding organic solvents such as acetone or ethanol or various surfactants to the aqueous medium. In this way, a reaction solution containing SAH is obtained, but
A known method may be used to collect SAH from the reaction solution. As a separation method, for example, SAH
By contacting the containing liquid with a strongly acidic cation exchange resin,
After adsorbing SAH, it is eluted with sulfuric acid, and phosphotungstic acid is added to the eluate to precipitate SAH.
After adsorption, it was eluted with ethanol/water/concentrated ammonia water (5:50:1), the eluate was concentrated under reduced pressure, and the pH of the concentrate was adjusted to 7 with acetic acid.
Examples include a method of crystallizing SAH at 0°C. The present invention will be explained in more detail with reference to Examples below. However, the present invention is not limited to these examples. In addition, the quantification of SAH in Examples was performed as follows. That is, after the reaction was completed, the reaction solution was immediately cooled to 0 to 5°C, and perchloric acid was added to stop the reaction. Next, insoluble matters were removed by centrifugation, and then a potassium phosphate buffer (PH7.0) was added to the resulting supernatant, and the generated potassium perchlorate was removed by centrifugation. A predetermined amount of the supernatant thus obtained was collected and SAH was quantified using high performance liquid chromatography (manufactured by Hitachi, Model 638-30, Column: Cosmocil 5C 18 , Detector: UV 260 nm). Example 1 Glucose 5g/dl, peptone 0.5g/dl, yeast extract 0.1g/dl, KH 2 PO 4 0.2g/dl,
K 2 HPO 4 0.1g/dl, MgSO 4・7H 2 O0.02g/dl,
In an agar slant medium (PH6.0) consisting of 2 g/dl agar.
A loopful of strain 1 listed in Table 1 cultured at 28°C for 48 hours was treated with glucose 5g/dl, peptone 0.5g/dl,
Yeast extract 0.1g/dl, KH 2 PO 4 0.2g/dl,
K 2 HPO 4 0.1g/dl, Mg SO 4・7H 2 O0.02g/dl
A liquid medium sterilized and adjusted to pH 6.5 consisting of 10
ml and cultured with shaking at 28°C for 40 hours. After collecting bacteria by centrifugation and washing with 0.1M sodium phosphate buffer (PH8.5), the bacterial cells were mixed with a substrate consisting of 2mM adenosine, 4mM DL homocysteine, and 100mM sodium phosphate buffer (PH8.5). The mixture was suspended in 1 ml of solution and reacted by shaking at 30°C for 4 hours. The yield of SAH was measured and the results are shown in Table 1.
【表】【table】
【表】
実施例 2
液体培地量が5mlであること以外は実施例1と
同様に培養したキヤンデイダ・ウチリスIFO
0396の培養液5mlをIN NaOHでPH8.5に調整し
た後、アデノシン5μmol、DE−ホモシステイン
5μmolを添加し、30℃で4時間振盪して反応させ
た。SAHの収量は0.24μmol/mlであつた。
実施例 3
液体培地量が500mlであること以外は実施例1
と同様に培養したサツカロマイセス・セレビジエ
IFO 1805の培養液より菌体を遠心分離にて集菌
し、生理食塩水で一回洗浄した後、再び遠心分離
にて集菌した。次にこの洗浄菌体を用いて下記の
手順に従い風乾菌体、凍結乾燥菌体及びアセトン
乾燥菌体はそれぞれ調整した。
すなわち洗浄菌体を通風下に約15時間室温にて
乾燥した後、更に五酸化リンを入れた減圧デシケ
ーター中5℃で1日乾燥した。次にこの乾燥菌体
を乳鉢で粉末状にすりつぶし、再び減圧デシケー
ター中で乾燥することにより風乾菌体を調整し
た。凍結乾燥菌体は、洗浄菌体をそのまま真空凍
結乾燥を行うことにより調整した。またアセトン
乾燥菌体は、洗浄菌体を5℃に冷却した500倍容
量のアセトン中に添加し、5分間撹拌した後、
過にて菌体を集め脱水アセトンで洗浄した後、減
圧でアセトンを留去することにより調整した。次
いでこれら3種類の乾燥菌体それぞれ50mgをアデ
ノシン2mM、DL−ホモシステイン4mM、リ
ン酸カリウムバツフアー(PH6.5)100mMからな
る基質溶液1mlに懸濁し、37℃で4時間振盪して
反応させた。それぞれのSAH合成量を第2表に
示した。[Table] Example 2 Candeida utilis IFO cultured in the same manner as in Example 1 except that the amount of liquid medium was 5 ml.
After adjusting 5 ml of culture solution of 0396 to pH 8.5 with IN NaOH, add 5 μmol of adenosine and DE-homocysteine.
5 μmol was added and the mixture was shaken and reacted at 30° C. for 4 hours. The yield of SAH was 0.24 μmol/ml. Example 3 Example 1 except that the liquid medium volume was 500 ml
Satucharomyces cerevisiae cultured in the same manner as
Bacterial cells were collected from the IFO 1805 culture solution by centrifugation, washed once with physiological saline, and collected again by centrifugation. Next, air-dried cells, freeze-dried cells, and acetone-dried cells were prepared using the washed cells according to the following procedure. That is, the washed bacterial cells were dried at room temperature under ventilation for about 15 hours, and then further dried at 5° C. for 1 day in a vacuum desiccator containing phosphorus pentoxide. Next, the dried bacterial cells were ground into powder in a mortar and dried again in a vacuum desiccator to prepare air-dried bacterial cells. Freeze-dried bacterial cells were prepared by directly vacuum-freezing the washed bacterial cells. In addition, for acetone-dried bacterial cells, the washed bacterial cells were added to 500 times the volume of acetone cooled to 5°C, and after stirring for 5 minutes,
The cells were collected in a vacuum, washed with dehydrated acetone, and then the acetone was distilled off under reduced pressure. Next, 50 mg of each of these three types of dried bacterial cells were suspended in 1 ml of a substrate solution consisting of 2 mM adenosine, 4 mM DL-homocysteine, and 100 mM potassium phosphate buffer (PH6.5), and the mixture was shaken at 37°C for 4 hours to react. Ta. The amount of SAH synthesized for each is shown in Table 2.
【表】
実施例 4
実施例3と同じ培養方法及び乾燥方法で調整し
た第3表に示す各菌株の風乾菌体50mgを使用し、
実施例3と同様に反応させた。SAHの収量を第
3表に示した。[Table] Example 4 Using 50 mg of air-dried bacterial cells of each strain shown in Table 3 prepared using the same culture method and drying method as in Example 3,
The reaction was carried out in the same manner as in Example 3. The yield of SAH is shown in Table 3.
【表】
実施例 5
実施例3と同じ培養方法及び乾燥方法で調整し
たサツカロマイセス・セレビジエIFO 1805の風
乾菌体50mgをアデノシン10mM、L−ホモシスチ
ン10mM、リン酸カリウムバツフアー(PH8.0)
100mMからなる基質溶液1mlに懸濁し、37℃で
4時間反応させた。SAHの収量は3.96μmo/ml
であつた。
実施例 6
実施例3と同じ方法で調整したサツカロマイセ
ス・セレビジエIFO 1805の風乾菌体200mgを10m
Mリン酸カリウムバツフアー(PH7.0)2mlに加
えて懸濁し、氷冷したのちアクリルアミド375mg、
N,N′−メチレンビスアクリルアミド20mg、5
%のN,N,N′,N′−テトラメチレンジアミン
水溶液0.25mlを加えて溶解させ、減圧にして脱気
した後、2.5%の過硫酸アンモニウム水溶液0.25
mlを加えて氷冷下に静置した。1時間後生成した
菌体含有ゲルを細かく粉砕し、10mMリン酸カリ
ウムバツフアー(PH7.0)で洗浄し菌体固定化物
を調整した。この固定化物1.9gをアデノシン10
mM、DL−ホモシステインmM、リン酸ナナト
リウムバツフアー(PH9.0)100mMからなる基質
溶液2mlに加え、30℃で8時間反応させた。
SAHの収量は1.10μmol/mlであつた。
実施例 7
実施例3と同じ方法で調整したサツカロマイセ
ス・セレビジエIFO 1805の風乾菌体2.5gをアデ
ノシン10mM、DL−ホモシステイン10mM、リ
ン酸ナトリウムバツフアー(PH9.5)100mMから
なる基質溶液50mlに懸濁し、37℃で6時間反応さ
せたところ、反応液中に238μmol(90mg)のSAH
が合成された。その後、氷冷下30%過塩素酸水溶
液5mlを添加して反応を停止した後、遠心分離に
より菌体残渣などの不溶物を除去した。次いで、
得られた上清液にIMKHCO3水溶液を添加しPH
6.0に調整し、生成した過塩素酸カリウムの沈殿
を遠心分離にて除去した。かくして得られた上清
液を強酸性陽イオン交換樹脂ダウエツクス50×8
(H+型)カラムに、通液したのちカラムを0.025
%チオジグリコール水溶液および0.025%チオジ
グリコール含有2N硫酸で洗浄したのち、0.025%
チオジグリコール含有6N硫酸で溶出される部分
を集めて、これに20%リンタングステン酸水溶液
を添加し、生成した沈殿物を遠心分離にて集めて
冷水で洗浄したのち、5倍容量のアセトン/水
(50/50・V/V)に溶解し、イソアミルアルコ
ール/エーテル(1/1・V/V)で抽出した
後、得られた水層にBaCO3を加えてPHを3.9に調
整し、生成したBaSO4をロカにて除去した上清
液を凍結乾燥したところ、白色固体物が53mg得ら
れた。シリカゲル薄層クロマトグラフイー、高速
液体クロマトグラフイー、ペーパークロマトグラ
フイー、赤外吸収スペクトル、比旋光度を測定し
たところ、この白色固体物はSAHであることが
確認された。[Table] Example 5 50 mg of air-dried bacterial cells of Satucharomyces cerevisiae IFO 1805 prepared using the same culture and drying methods as in Example 3 were mixed with 10 mM adenosine, 10 mM L-homocystine, and potassium phosphate buffer (PH8.0).
It was suspended in 1 ml of a 100 mM substrate solution and reacted at 37°C for 4 hours. SAH yield is 3.96μmo/ml
It was hot. Example 6 200 mg of air-dried bacterial cells of Satucharomyces cerevisiae IFO 1805 prepared in the same manner as in Example 3 were placed in a 10 m
Add to 2 ml of M potassium phosphate buffer (PH7.0), suspend, cool on ice, and add 375 mg of acrylamide.
N,N'-methylenebisacrylamide 20mg, 5
Add and dissolve 0.25 ml of a 2.5% aqueous solution of N,N,N',N'-tetramethylenediamine, degas under reduced pressure, and add 0.25 ml of a 2.5% aqueous solution of ammonium persulfate.
ml was added and left to stand under ice-cooling. The bacterial cell-containing gel produced after 1 hour was finely ground and washed with 10 mM potassium phosphate buffer (PH7.0) to prepare a bacterial cell immobilized product. Add 1.9 g of this immobilized material to adenosine 10
The mixture was added to 2 ml of a substrate solution consisting of mM, DL-homocysteine, and 100 mM sodium phosphate buffer (PH9.0), and the mixture was reacted at 30°C for 8 hours.
The yield of SAH was 1.10 μmol/ml. Example 7 2.5 g of air-dried cells of Saccharomyces cerevisiae IFO 1805 prepared in the same manner as in Example 3 were added to 50 ml of a substrate solution consisting of 10 mM adenosine, 10 mM DL-homocysteine, and 100 mM sodium phosphate buffer (PH9.5). When suspended and reacted at 37°C for 6 hours, 238 μmol (90 mg) of SAH was found in the reaction solution.
was synthesized. Thereafter, the reaction was stopped by adding 5 ml of a 30% perchloric acid aqueous solution under ice cooling, and then insoluble matter such as bacterial cell residue was removed by centrifugation. Then,
Add IMKHCO 3 aqueous solution to the obtained supernatant to adjust the pH.
6.0, and the generated potassium perchlorate precipitate was removed by centrifugation. The supernatant liquid obtained in this way was transferred to a strongly acidic cation exchange resin Dowex 50×8.
After passing the liquid through the (H + type) column, the column was 0.025
After washing with % thiodiglycol aqueous solution and 2N sulfuric acid containing 0.025% thiodiglycol, 0.025%
The fraction eluted with 6N sulfuric acid containing thiodiglycol was collected, and a 20% aqueous phosphotungstic acid solution was added thereto. The resulting precipitate was collected by centrifugation and washed with cold water, followed by 5 times the volume of acetone/ After dissolving in water (50/50 V/V) and extracting with isoamyl alcohol/ether (1/1 V/V), BaCO 3 was added to the resulting aqueous layer to adjust the pH to 3.9. When the supernatant liquid from which BaSO 4 was removed was freeze-dried, 53 mg of a white solid was obtained. When silica gel thin layer chromatography, high performance liquid chromatography, paper chromatography, infrared absorption spectrum, and specific rotation were measured, this white solid was confirmed to be SAH.
Claims (1)
属しアデノシンとホモシステインよりS−アデノ
シル−L−ホモシステインを合成する能力を有す
る微生物の菌体の存在下にアデノシンとホモシス
テインを水性媒体中で接触させて反応せしめ、S
−アデノシル−L−ホモシステインを合成して採
取することを特徴とするS−アデノシル−L−ホ
モシステインの製造法。 2 微生物の菌体が生菌体または乾燥菌体である
特許請求の範囲第1項記載の製造法。[Claims] 1. Adenosine and homocysteine are synthesized in an aqueous medium in the presence of a microorganism belonging to the genus Satucharomyces or Candeida that has the ability to synthesize S-adenosyl-L-homocysteine from adenosine and homocysteine. Contact and react, S
- A method for producing S-adenosyl-L-homocysteine, which comprises synthesizing and collecting adenosyl-L-homocysteine. 2. The production method according to claim 1, wherein the microorganism cells are live cells or dry cells.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2080883A JPS59146596A (en) | 1983-02-10 | 1983-02-10 | Preparation of s-adenosyl-l-homocysteine |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2080883A JPS59146596A (en) | 1983-02-10 | 1983-02-10 | Preparation of s-adenosyl-l-homocysteine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS59146596A JPS59146596A (en) | 1984-08-22 |
| JPH0260318B2 true JPH0260318B2 (en) | 1990-12-14 |
Family
ID=12037334
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2080883A Granted JPS59146596A (en) | 1983-02-10 | 1983-02-10 | Preparation of s-adenosyl-l-homocysteine |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS59146596A (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS59146595A (en) * | 1983-02-10 | 1984-08-22 | Nippon Zeon Co Ltd | Preparation of s-adenosyl-l-homocysteine |
| JPS6030679A (en) * | 1983-07-29 | 1985-02-16 | Nippon Zeon Co Ltd | Preparation of s-adenosyl-l-homocysteine hydrolase |
-
1983
- 1983-02-10 JP JP2080883A patent/JPS59146596A/en active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS59146596A (en) | 1984-08-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPH0357760B2 (en) | ||
| JPH0630599B2 (en) | Process for producing fructose-1,6-diphosphate | |
| JPH0260318B2 (en) | ||
| US4605625A (en) | Process for producing S-adenosyl-L-homocysteine | |
| JPS59102389A (en) | Biological production of microorganism metabolite and enzyme | |
| US4596775A (en) | Microorganism and its use for the preparation of glutathione | |
| US5008188A (en) | Process for producing S-adenosyl-L-homocysteine | |
| JP3030916B2 (en) | Method for producing β-glucooligosaccharide | |
| RU2230118C2 (en) | METHOD FOR PREPARING 1-β-D-RIBOFURANOSYL-1,2,4-TRIAZOLE-3-CARBOXAMIDE (RIB AVIRIN) | |
| JPS60145095A (en) | Preparation of xylitol by immobilized microorganism | |
| JP3482454B2 (en) | Method for producing high-purity xyloglucan oligoheptasaccharide | |
| JPH0458317B2 (en) | ||
| JPH0998779A (en) | Trehalose synthase, method for producing the same, and method for producing trehalose using the same | |
| JPS6224076B2 (en) | ||
| JPS6339235B2 (en) | ||
| JPH0157959B2 (en) | ||
| JPS58212783A (en) | Preparation of phospholipase a by fermentation method | |
| JPS6339236B2 (en) | ||
| JP2946055B2 (en) | Method for producing optically active (S)-(+)-3-halo-1,2-propanediol | |
| JPS6317439B2 (en) | ||
| JP2548553B2 (en) | Method for producing glutaminase | |
| JPS61242588A (en) | Production of beta-hydroxynitrile | |
| JPH0569515B2 (en) | ||
| SU667558A1 (en) | Method of producing d-rybozo-1,5-diphosphate | |
| JP2627755B2 (en) | Production of acylneulaminate cytidyltransferase |